For the year ending 2025-12-31, ACRS made $7,826K in revenue. -$64,410K in net income. Net profit margin of -823.03%.
| Income Statement | 2025-12-31 | 2024-12-31 | ||
|---|---|---|---|---|
| Total revenue | 7,826 | 18,720 | ||
| Cost of revenue | 2,091 | 2,792 | ||
| Research and development | 52,645 | 33,586 | ||
| General and administrative | 21,972 | 22,203 | ||
| In-process research and development | - | 86,905 | ||
| Licensing | 5,193 | 12,666 | ||
| Revaluation of contingent consideration | 2,300 | 2,500 | ||
| Total costs and expenses | 84,201 | 160,652 | ||
| Loss from operations | -76,375 | -141,932 | ||
| Interest income | 7,637 | 7,953 | ||
| Non-cash royalty income | 3,815 | 1,914 | ||
| Total other income | 11,452 | 9,867 | ||
| Loss before income taxes | - | -132,065 | ||
| Net loss | -64,923 | -132,065 | ||
| Unrealized gain on marketable securities, net of tax of 0 | 513 | 203 | ||
| Total other comprehensive income | 513 | 203 | ||
| Comprehensive loss | -64,410 | -131,862 | ||
| Basic EPS | -0.53 | -1.71 | ||
| Diluted EPS | -0.53 | -1.71 | ||
| Basic Average Shares | 122,564,741 | 77,296,665 | ||
| Diluted Average Shares | 122,564,741 | 77,296,665 | ||
Aclaris Therapeutics, Inc. (ACRS)
Aclaris Therapeutics, Inc. (ACRS)